César López-Camacho
Dr. César López-Camacho is currently a Senior Researcher at the Jenner Institute where he works on genetic-vaccine development for arthropod-borne pathogens, with a special interest in tick-borne pathogens.
He holds a PhD in Molecular Biology from the University of Manchester, United Kingdom, and has held four postdoctoral positions in molecular biology, fidelity of gene expression, and vaccinology at UMASS Medical School-USA, University of Vermont College of Medicine-USA and the Jenner Institute at University of Oxford, respectively.
His contribution encompasses the development of a Zika virus vaccine, a Chikungunya virus vaccine and other vaccines for infectious agents (HPV, T. cruzi and malaria).
He is interested in antigen design and optimisation of antigen expression in vivo.
During the coronavirus pandemic, his scientific activity encompassed the design and protein production of SARS-CoV-2 antigens to be utilised as diagnostic tools, for coronavirus research applications and for the exploration of the immune responses in COVID-19 convalescent individuals.
In terms of intellectual property activities, he is an inventor and collaborator in vaccine-related patents and he is an author in more than 30 scientific publications related to vaccinology.